FTHWF - Field Trip Health & Wellness Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0412
0.0000 (0.00%)
At close: 03:57PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.0412
Open0.0296
BidN/A x N/A
AskN/A x N/A
Day's Range0.0412 - 0.0412
52 Week Range0.0177 - 0.5000
Volume86,270
Avg. Volume13,446
Market Cap3.713M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FTHWF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • CNW Group

    TSX Venture Exchange Stock Maintenance Bulletins

    TSX VENTURE COMPANIES

  • GlobeNewswire

    Field Trip Health & Wellness Obtains CCAA Protection

    TORONTO, March 22, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) (“Field Trip” or the “Company”) today announced that it has obtained an Order (the “Initial Order”) for creditor protection from the Ontario Superior Court of Justice (Commercial List) (the “Court”) under the Companies’ Creditors Arrangement Act (the “CCAA”). PricewaterhouseCoopers Inc. has been appointed as the CCAA monitor (the “Monitor”). After careful consideration of the Company’s cash position and a

  • CNW Group

    IIROC Trading Halt - FTHW

    The following issues have been halted by IIROC:

  • GlobeNewswire

    Field Trip Health & Wellness to Close Clinics in 5 Locations

    TORONTO, March 15, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”) today announced that, in an effort to reduce expenditures and preserve capital, it will be closing the Field Trip Health Centres located in Chicago, Washington DC, Seattle, San Diego and Fredericton. The anticipated last day of operation for each of these locations will be on or around April 15, 2023. Clients in each of these locations will be receiving notice of clinic clo

  • GlobeNewswire

    Field Trip Health & Wellness Provides Business Update and Reports Fiscal Third Quarter 2023 Results

    TORONTO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (OTCQB: FTHWF) (the "Company" or "Field Trip"), a global leader in the delivery of psychedelic therapies, provided a business update today and reported its fiscal third quarter 2023 results for the three and nine month periods ended December 31, 2022. All results are reported in accordance with International Financial Reporting Standards and in Canadian dollars, unless otherwise specified. In December 2022,

  • GlobeNewswire

    Field Trip Health & Wellness Ltd. to Release Fiscal 2023 Third Quarter Financial Results on Tuesday, February 28, 2023

    TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (OTCQB: FTHWF) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 third quarter ended December 31, 2022, after market close on Tuesday, February 28, 2023. In addition, the Company announced that its Board of Directors has established an Independent Committee (IC) to explore strategic option

  • GlobeNewswire

    Field Trip Health & Wellness Announces Posting on the OTC Market

    Trading on the OTCQB Effective February 2, 2023, under the Symbol “FTHWF”TORONTO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), global leader in the delivery of psychedelic therapies, is pleased to announce that the Company has received approval from the Financial Regulatory Authority (“FINRA”) for its shares to commence trading on the OTCQB Market (“the OTCQB”) in the United States under the symbol “FTHWF” effective February 2,

  • GlobeNewswire

    Field Trip Health & Wellness Ltd. Announces Launch of Online Therapy

    The new program, which builds on Field Trip’s clinically proven ketamine therapies, will provide people with a non-ordinary approach to psychotherapyTORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”), a global leader in the delivery of psychedelic therapies, today launched Field Trip Online Therapy, a unique approach to psychotherapy that leverages contemporary talk therapy, integrative wellness tools and insights derived fr

  • GlobeNewswire

    KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing

    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the presentations from its KCSA Mental Health Virtual Investor Conference held on December 15th are now available for online viewing. REGISTER NOW AT: https://bit.ly/3FPSRgWThe company presentations will be

  • GlobeNewswire

    Field Trip Health & Wellness To Webcast Live at the KCSA Mental Health Conference on December 15th

    TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, today announced that Ronan Levy, Chairman & Chief Executive Officer of Field Trip Health & Wellness, will webcast live at the KCSA Mental Health Conference, hosted by VirtualInvestorConferences.com, on Thursday, December 15th, 2022. DATE: December 15, 2022TIME: 11:00 a.m. ETLINK: https://bit.ly/3Ub0iE3 A recording of

  • GlobeNewswire

    KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Mental Health Virtual Investor Conference to be held on Thursday, December 15, 2022. Individual investors, institutional investors, advisors, and analysts are invited to atte

  • GlobeNewswire

    Field Trip Health & Wellness Provides Business Update And Reports Fiscal Second Quarter 2023 Results

    Post-quarter end, launched a refreshed version of the Company’s award-winning app for psychedelic guidance, renamed ‘Field Trip’, to include a number of new features, such as offline access to music and meditations, higher bit-rate streaming and access to Field Trip’s therapeutic programs.In November, announced ‘Freedom by Field Trip™’, a first-of-its-kind, one-year hybrid ketamine therapy program blending psychedelic-assisted therapies with holistic wellness support to offer people the ability

  • GlobeNewswire

    Field Trip Health & Wellness Ltd. Announces Updated Time for Fiscal Second Quarter 2023 Financial Results and Conference Call

    Management to Hold Fiscal Second Quarter 2023 Conference Call on Wednesday, November 30, 2022, at 8:30 AM ETTORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" of “Field Trip”), a global leader in the delivery of psychedelic therapies, announced today that it now plans to release financial results for its fiscal 2023 second quarter for the three-month period ended September 30, 2022, after market close on Tuesday, November 29, 2022. The Compan

  • GlobeNewswire

    Field Trip Health & Wellness Ltd. Strengthens Leadership Team With Two Executive Appointments, Schedules Fiscal Second Quarter 2023 Conference Call

    Appoints Stacey Hoisak as Senior Vice President, General Counsel, and Dr. Monique Moller as Vice President, Integrative HealthSchedules Fiscal Second Quarter 2023 Conference Call for Tuesday, November 29, 2022, at 8:30 AM ET TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, today announced that it has strengthened its leadership team with the hiring of two senior exe

  • GlobeNewswire

    Field Trip Announces the Launch of Freedom by Field Trip™, a First-of-Its-Kind Ketamine Therapy Program

    The One Year Wellness Journey Blends Field Trip’s Proven Ketamine-Assisted Therapies with a Holistic Membership Program to Help People Heal and Make Lasting ChangeTORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”), a global leader in the delivery of psychedelic therapies, today launched Freedom by Field Trip™ (the “Program”), a first-of-its-kind one-year hybrid ketamine therapy program that blends the power of psychedelic-as

  • GlobeNewswire

    Field Trip Health & Wellness Releases Letter to Shareholders

    TORONTO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in the development and delivery of psychedelic therapies, today released the following letter to shareholders from the Company’s Chairman & Chief Executive Officer, Ronan Levy, and President, Mujeeb Jafferi. Dear Shareholders: We would like to take this opportunity to provide an update on the direction of our business, as we recognize that the rate of change

  • GlobeNewswire

    Field Trip Health & Wellness to Participate in Upcoming November Conferences

    TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), the global leader in the development and delivery of psychedelic therapies, will participate in the following industry and investor conferences in November. Wonderland Microdose Format: Panel Presentation with Mujeeb Jafferi, President, Field Trip Health & Wellness, “Are Apps the Future of Psychedelic Therapy?”Date/Time: Friday, November 4, at 1:20 p.m. ETLocation: Second St

  • GlobeNewswire

    Field Trip Announces Relaunch and Refresh of Its Award-Winning Psychedelic App

    The app, now called Field Trip, includes new features, new content, and is part of the Company’s new community-focused, digital-centric growth strategyTORONTO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the “Company”), the global leader in the development and delivery of psychedelic therapies, is pleased to announce that a new version of its award-winning app for psychedelic guidance is now available for download on the App Store and Google

  • GlobeNewswire

    Field Trip Health & Wellness to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics on October 11th

    TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, today announced it will participate in a virtual fireside chat at Cantor Fitzgerald’s “Symposium on Mental Health Clinics,” taking place on Tuesday, October 11, 2022. Mujeeb Jafferi, President of Field Trip, will present at the virtual fireside chat at 8:00 a.m. Eastern Time on Tuesday, October 11, 2022. To view the fireside chat, pl

  • WSJ

    Investors Bet Ketamine Treatment Will Revolutionize Mental-Health Care

    Hundreds of clinics specializing in ketamine treatment for depression and other mood disorders have popped up in the U.S. in recent years. WSJ visits one clinic, Nushama, to learn why some entrepreneurs are betting that demand for ketamine will continue to rise. Photo illustration: Laura Kammermann/WSJ

  • GlobeNewswire

    Field Trip Health & Wellness to Present at the H.C. Wainwright 24th Annual Global Investment Conference

    Announces Grant of Stock Options to Directors and OfficersTORONTO, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, today announced it will participate in a virtual fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022. A recording of the fireside chat will be available on demand from 7:00 a.m. Eastern Time on Monday, September 12,

  • GlobeNewswire

    Field Trip Health & Wellness Ltd. Reports Fiscal First Quarter 2023 Financial and Operating Results

    Completed corporate reorganization on August 11, 2022 separating the drug development (“Reunion Neuroscience Inc.” or “Reunion”) and healthcare and wellness (“Field Trip Health & Wellness” or “Field Trip”) divisions into two separate public companies (the “Spinout Transaction”).Field Trip received listing approval from the TSX Venture Exchange (“TSX-V”) and commenced trading on August 17, 2022 under new ticker symbol “FTHW”.Concurrent with the closing of the Spinout Transaction, completed a seri

  • GlobeNewswire

    Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M. ET

    TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first quarter for the three-month period ended June 30, 2022, after market close on Monday, August 29, 2022. The Company will conduct a conference call and webcast to discuss its results the following morning, Tuesday, August 30, 2022 at 8:30 a.m. ET. To a